Sickle Cell Syndromes, An Issue of Hematology/Oncology Clinics of North America

Timely, relevant discussions on sickle cell syndromes

Sophie Lanzkron (Edited by), Jane Little (Edited by)

9780323986632, Elsevier Health Sciences

Hardback, published 18 November 2022

240 pages
28 x 19 x 2.1 cm, 0.59 kg

In this issue of Hematology/Oncology Clinics, guest editors Drs. Sophie Lanzkron and Jane Little bring their considerable expertise to the topic of Sickle Cell Syndromes. Top experts in the field cover key topics such as structural racism and impact on sickle cell disease (SCD); pathophysiology and biomarkers of SCD; genetic modifiers of SCD; allogeneic transplant and gene therapy: reproductive health; chronic pain; and more.

• Contains 16 relevant, practice-oriented topics including innovative therapies, addressing challenging complications, novel science on mechanisms of disease; preventing cognitive decline in people with SCD; quality of life in SCD; and more.

• Provides in-depth clinical reviews on sickle cell syndromes, offering actionable insights for clinical practice.

• Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

Structural Racism and Impact on Sickle Cell Disease: Sickle Cell Lives MatterSickle Cell Disease Pathophysiology and Related Molecular and Biophysical BiomarkersGenetic Modifiers of Sickle Cell DiseaseEconomics of Sickle Cell Disease and Evidence to Support Comprehensive CareQuality of Life in Sickle Cell Disease: What MattersChronic Pain: Prevalence and ManagementThe Development of Neuroimaging Biomarkers for Cognitive Decline in Sickle Cell DiseaseClinical Vignettes Part IClinical Vignettes Part IIThe Cardiopulmonary Complications of Sickle Cell DiseaseSickle Cell Disease and the Kidney: Filters Gone AwryGo the Distance: Reproductive Health Care for People with Sickle Cell DiseaseGenotyping and the Future of Transfusion in Sickle Cell DiseaseThe Evolving Landscape of Drug Therapies for Sickle Cell DiseaseAllogeneic Transplant and Gene Therapy: Evolving Toward a Cure

Subject Areas: Haematology [MJF]